Pterocarpadiol C exhibits potential in pharmaceutical research due to its structural similarity to bioactive flavonoids and pterocarpans known for antioxidant and anti-inflammatory properties. It has been investigated for its role in modulating cellular pathways related to oxidative stress and inflammation, making it a candidate for studies in neurodegenerative and metabolic disorders. Preliminary in vitro studies suggest it may influence cell viability and protect against oxidative damage in neuronal cells. Its application remains primarily in early-stage research, particularly in natural product chemistry and drug discovery, where it serves as a lead compound for developing derivatives with enhanced bioactivity.